Texas OTC Medtech Firm Refuses FDA Inspection, Continues Selling Unapproved Products
RoyalVibe Health makes and sells unapproved devices in kits and individually “intended for the diagnosis and treatment of several diseases including but not limited to cancer, Alzheimer’s, ischemic stroke, arthritis, and type 1 diabetes,” FDA warning states.
You may also be interested in...
The US FDA is warning consumers to stay away from medical devices manufactured by a Texas firm because they have not been approved by the agency and their use may do more harm than good.
Since closing at a 14-year low of $8.07 the day of the execs’ transactions, Herbalife shares trend steadily up from close of $8.26 on 20 February to $8.83 on 29 February. Some execs sell back some shares on 25 February at $8.67.
Perrigo doesn’t attempt to diminish significance of challenge to regain sales growth in formula market as it resets its plants. Analysts see formula business as only current impediment to stronger results.